MedTrace Logo

Type 1 Diabetes and Obstructive Sleep Apnea

NCT06915831 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-01-20

No results posted yet for this study

Summary

The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.

Conditions

  • Sleep Apnea, Obstructive
  • Type 1 Diabetes (T1D)

Interventions

DEVICE

Continuous positive airway pressure (CPAP)

All-night CPAP will be applied with bedtimes 23:00h to 7:00h.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Esra Tasali, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-10
Primary Completion
2029-08-31
Completion
2029-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06915831 on ClinicalTrials.gov